Tag Archives: Avastin
PDL BioPharma drops on lower 4Q revenue forecast
PDL BioPharma (NASDAQ:PDLI) has dropped by more than 2.6 percent today after the company announced that it expects fourth quarter profits to drop by about 5 percent due to lower royalty payments for cancer drugs Avastin and Herceptin.
Both Avastin …
















